Characterization of Green Synthesized Nanoparticles with Anti-diabetic Properties. A Systematic Review
- 1 January 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 21 (7) , 1-19
Abstract
Background: Plants are used in medicine because they are low-cost, widely available, and have few side effects (compared to pharmacological treatment). Plants have phytocompounds with antidiabetic properties that can be delivered using nanoparticles (NPs). Objective: To describe the antidiabetic properties of green synthesized NPs (GSNPs) and their characterization methods. Methods: Three databases were searched using the terms “type 2 diabetes mellitus,” “antidiabetic effects,” “phytochemicals,” “plants,” and “nanoparticles.” Studies describing the antidiabetic effects (in vitro or animal models) of NPs synthesized by plant extracts and characterizing them through UV-Vis spectroscopy, FTIR, XRD, SEM, TEM, and DLS were included. Results: 16 studies were included. In vitro studies reported enzyme inhibition values between 11% (H. polyrhizus) and 100% (A. concinna) for alfa-amylase and between 41.1% (M. zapota) and 100% (A. concinna) for alfa-glucosidase. Animal studies with Wistar Albino rats having diabetes (induced by alloxan or streptozotocin) reported improved blood glucose, triglycerides, total cholesterol, LDL, and HDL after treatment with GSNPs. Regarding characterization, NP sizes were measured with DLS (25-181.5 nm), SEM (52.1-91 nm), and TEM (8.7-40.6 nm). The surface charge was analyzed with zeta potential (-30.7 to -2.9 mV). UV-Vis spectroscopy was employed to confirm the formations of AgNPs (360-460 nm), AuNPs (524-540 nm), and ZnONPs (300-400 nm), and FTIR was used to identify plant extract functional groups. Conclusions: GSNP characterization (shape, size, zeta potential, and others) is essential to know the viability and stability, which are important to achieve health benefits for biomedical applications. Studies reported good enzyme inhibition percentages in in vitro studies, decreasing blood glucose levels and improving lipid profiles in animal models with diabetes. However, these studies had limitations in the methodology and potential risk of bias, so results need careful interpretation.Keywords
This publication has 87 references indexed in Scilit:
- Phytogenic nanoparticles: synthesis, characterization, and their roles in physiology and biochemistry of plantsBioMetals, 2023
- Critical Review on Nutritional, Bioactive, and Medicinal Potential of Spices and Herbs and Their Application in Food Fortification and NanotechnologyApplied Biochemistry and Biotechnology, 2022
- A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetesPhytochemistry Reviews, 2021
- Novel Gold Nanoparticles: Green Synthesis with Eryngium thyrsoideum Boiss Extract, Characterization, and In Vivo Investigations on Inflammatory Gene Expression and Biochemical Parameters in Type 2 Diabetic RatsBiological Trace Element Research, 2021
- Biogenesis of silver nanoparticles to treat cancer, diabetes, and microbial infections: a mechanistic overviewApplied Microbiology and Biotechnology, 2021
- Biosynthesis of Novel Silver Nanoparticles Using Eryngium thyrsoideum Boiss Extract and Comparison of their Antidiabetic Activity with Chemical Synthesized Silver Nanoparticles in Diabetic RatsBiological Trace Element Research, 2020
- Critical review on conventional spectroscopic α‐amylase activity detection methods: merits, demerits, and future prospectsJournal of the Science of Food and Agriculture, 2020
- Nanoparticle Characterization: What to Measure?Advanced Materials, 2019
- Experimental methods in chemical engineering: Ultraviolet visible spectroscopy—UV‐VisThe Canadian Journal of Chemical Engineering, 2018
- The mechanisms of alloxan- and streptozotocin-induced diabetesDiabetologia, 2007